Necon Kit
Product Images NDC 51862-892

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Necon (NDC 51862-892). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 01)

Chemical structure image showing norethindrone on the left and ethinyl estradiol on the right, the active ingredients in Necon kit. Each structure is labeled with its respective name below the molecular diagram.*

FDA Label Image

2 (Image 02)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Women-Years by Age, Smoking Status and Oral Contraceptive Use' showing mortality rates for women in age groups 15-24, 25-34, 35-44, and 45+. The chart compares four groups: ever-users (non-smokers), controls (non-smokers), ever-users (smokers), and controls (smokers), with mortality rates increasing notably in older age groups and highest among smokers who are ever-users of oral contraceptives.*

FDA Label Image

3 (Image 03)

A boxed warning text panel advising against use of Necon tablets in individuals over 35 who smoke cigarettes. It highlights increased risk of serious cardiovascular side effects, including heart attack, blood clots, or stroke, with risk increasing by age and cigarette consumption.*

FDA Label Image

4 (Image 04)

Necon oral contraceptive kit blister card showing 28 tablets arranged in rows by weeks and days (Sunday to Saturday). Active light peach tablets are differentiated from inactive white tablets. Includes instructions and drug storage information, with labeler Mayne Pharma Inc. and NDC 51862-892 displayed.*

FDA Label Image

5 (Image 05)

An instructional diagram showing how to use the day label on a Necon oral contraceptive kit blister pack. It depicts the days of the week label to be peeled and placed on the kit, with example placement and color coding for active (light peach) and inactive (white) pills across weeks.*

FDA Label Image

6 (Image 06)

Warning text panel from Necon kit indicating not to use Necon tablets if the user smokes cigarettes and is over 35 years old, due to increased risk of serious cardiovascular side effects including heart attack, blood clots, or stroke. The warning highlights that risk increases with age and number of cigarettes smoked.*

FDA Label Image

7 (Image 07)

Necon norethindrone and ethinyl estradiol oral tablet kit blister card showing a 28-day cycle. The card features rows labeled Week 1 to Week 4 with daily tablet positions from Sunday to Saturday. Light peach circles indicate active tablets, and white circles indicate inactive tablets. The card includes instructions for use and manufacturer information from Mayne Pharma Inc.*

FDA Label Image

8 (Image 08)

An instructional illustration showing a hand peeling a day-of-the-week label strip and placing it on a Necon oral contraceptive pill kit. The kit contains circular pill compartments labeled with days and arrows, with light peach (active) and white (inactive) pills. The image guides correct label placement for tracking usage.*

FDA Label Image

9 (Image 09)

FDA Label Image

10 (Image 10)

Necon 0.5 mg/0.035 mg (norethindrone and ethinyl estradiol) oral tablet kit packaging label. The label indicates 3 blister cards of 28 tablets each (total 84 tablets), distributed by Mayne Pharma Inc. The label provides storage and dosage instructions and notes that this product is a prescription-only oral contraceptive.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.